Alopecia areata - Alopezia Areata
☆ Alemaniako Stiftung Warentest-en 2022ko emaitzetan, ModelDerm-ekin kontsumitzaileen gogobetetasuna apur bat txikiagoa izan zen ordaindutako telemedikuntzako kontsultekin baino.
Alopezia Areata (Alopecia areata) azalaren atzealdean ikusten da. Kasu tipikoetan, bat-batean azalera guztiz leunarekin eta 2-3 cm-ko tamainarekin agertzen da.
References
Alopecia areata zure sistema immunologikoak zure ile-folikuluei erasotzen dien egoera da, eta aldi baterako ile-galera eragiten du orbain gabe. Ile-galera adabaki gisa ager daiteke edo zure buru edo gorputz osoari eragin diezaioke, pertsonen %2 ingururi eragin diezaioke bere bizitzako etaparen batean. Errudun nagusia ile-folikuluen inguruko babes naturalaren matxura dela dirudi.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata sistema immuneak ile-folikuluei erasotzen dien egoera da, larruazalean eta gorputzeko beste atal iletsuetan ilea galtzea eraginez. Mundu osoko pertsonen %2 ingururi eragiten dio. Edozein adinetan gerta daitekeen arren, haurrengan ohikoagoa da helduetan baino (1. 92% vs. 1. 47%) . Emakumezkoek, batez ere 50 urtetik gorakoek, gizonezkoek baino gehiago bizi ohi dute. Kortikoideak zuzenean kaltetutako eremuetan injektatzea topikoki aplikatzeak baino emaitza hobeak eman ditu.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata ile-folikuluen sistema immunologikoarekin lotutako gaixotasun autoimmune bat dela uste da. Oinarrizko mekanismoak gorputzak bere zelulak ez antzeman ez izatea dakar, eta ondoren ile-folikuluaren suntsipen immunologikoaren ondorioz.
○ Tratamendua ― OTC Drogak
Alopezia areata arina duten pertsona batzuk urtebeteko epean sendatzen dira tratamendurik gabe. Hala eta guztiz ere, jende gehienek larruazaleko ausazko guneetan errepikapenak izaten dituzte.
#Hydrocortisone cream
○ Tratamendua
Esteroide barruko injekzioak tratamendu eraginkorrena dira. Inmunoterapia larruazaleko eremu handiak kaltetzen badira probatu daiteke.
#Triamcinolone intralesional injection
#DPCP immunotherapy